Jeff Jordan, Managing Partner, a16z says, "We invested in Levels because metabolic dysfunction is an incredibly important problem, and their rate of execution on solving this problem is on par with the best companies we've seen. "Consumers are increasingly health conscious, and increasingly leverage real tech tools and data to improve their health. Levels provides a veritable 'divining rod' for improved metabolic health."
Vijay Pande, PhD and General Partner, a16z adds, "The two most fundamental levers for our health – diet and exercise – remain shrouded in generalities and unrealistic advice. By harnessing CGMs, wearables, data science, and the latest advances in biology and medicine, Levels provides critical information to help consumers take control of diet and exercise, while making real, fundamental improvements in their health. Preventing metabolic dysfunction is one of the 21st century's greatest health challenges, and Levels addresses the epidemic head on."
Fitbit, Dexcom form diabetes health partnership
Sweat glucose sensor smartwatch is self-powered
Nano gas sensor powers wearable diabetic alert
Implantable health sensor runs off of body glucose
Wearables forecast looks to the next decade